Grant Disick, MD
Urology · Boca Raton, FLNPI 1639236797
Payments from drug & device makers
Across 258 payments — averaging $3115.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urovant Sciences Inc$495K
- AbbVie$272K
- GSK$34K
- Antares Pharma, Inc.$543
- Astellas Pharma US Inc$420
- Medtronic$283
- plus $2K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urovant Sciences Inc | 28 | $494,668 |
| AbbVie(2 entities) | 80 | $271,875 |
| GSK | 21 | $33,928 |
| Antares Pharma, Inc. | 22 | $543 |
| Astellas Pharma US Inc | 15 | $420 |
| Medtronic | 7 | $283 |
| Sumitomo Pharma America, Inc. | 11 | $225 |
| Coloplast | 11 | $215 |
| Boston Scientific | 6 | $186 |
| Urogen Pharma, Inc. | 1 | $141 |
| Pfizer | 6 | $132 |
| Baxter Healthcare | 1 | $115 |
| Endo Pharmaceuticals Inc. | 6 | $112 |
| Myovant Sciences Inc. | 5 | $98 |
| Convatec Inc. | 3 | $94 |
| AstraZeneca | 3 | $82 |
| Caldera Medical, Inc | 1 | $81 |
| Johnson & Johnson | 3 | $76 |
| Tolmar Pharmaceuticals, Inc. | 4 | $76 |
| Halozyme Inc | 3 | $68 |
| Dendreon Pharmaceuticals LLC | 2 | $58 |
| Tolmar, Inc. | 2 | $44 |
| Accord Healthcare, Inc. | 2 | $42 |
| Myriad Genetic Laboratories, Inc. | 2 | $41 |
| Novartis | 1 | $35 |
| Laborie Medical Technologies Corp. | 2 | $34 |
| Siemens Medical Solutions USA, Inc. | 1 | $32 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Procept Biorobotics Corporation | 1 | $23 |
| Teleflex LLC | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| ABC Home Medical Supply, Inc. | 1 | $19 |
| Bayer | 1 | $19 |
| Akcea Therapeutics, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
How this compares
$803,888 in reported general payments places this provider in the 95th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Boca Raton
- Steven KesterPompano Beach$5.7M
- Harvey SamowitzHallandale Beach$3.6M
- Paul PeritoCoral Gables$3.6M
- Graham GreeneLakeland$2.5M
- Scott SellingerTallahassee$2.3M
- Fernando BiancoHialeah$2.2M
- Osvaldo PadronTampa$1.3M
- Mark Anthony GonzalgoMiami$1.1M
- Paul CrispenGainesville$1.1M
- Craig HermanPompano Beach$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.